Physician profile
Amit Sudan
NPI 1689660953
$2,070.20
in general payments reported to CMS, 2019-2025
11 companies · $901 in 2025
The $901 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47.87 · 2020: $43.44 · 2021: $219 · 2022: $709 · 2023: $57.83 · 2024: $92.00 · 2025: $901.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $641 · Food and Beverage: $410.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $641.20 |
| Food and Beverage | $410.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merit Medical Systems INC | $827.66 | 2025 | Embosphere Microspheres, Swiftninja Sterble Cor Micro |
| Inari Medical, INC. | $576.44 | 2021-2022 | |
| Medtronic, INC. | $241.37 | 2022-2025 | Osteocool Rf Ablation System, Abre |
| Terumo Medical Corporation | $135.94 | 2022 | |
| Boston Scientific Corporation | $119.84 | 2020-2025 | Cryoablation Needles |
| W. L. Gore & Associates, INC. | $50.35 | 2024 | Gore Viabahn Endoprosthesis With Heparin |
| Medtronic Vascular, INC. | $46.58 | 2019-2020 | |
| Ethicon US, LLC | $26.61 | 2022 | |
| Biocompatibles, INC. | $16.92 | 2019 | |
| Getinge USA Sales, LLC | $16.61 | 2021 | |
| Bard Peripheral Vascular, INC. | $11.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Sudan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.